Unraveling the fatigue puzzle: insights into the pathogenesis and management of IBD-related fatigue including the role of the gut-brain axis
- PMID: 39021817
- PMCID: PMC11252009
- DOI: 10.3389/fmed.2024.1424926
Unraveling the fatigue puzzle: insights into the pathogenesis and management of IBD-related fatigue including the role of the gut-brain axis
Abstract
A significant percentage of patients with an inflammatory bowel disease (IBD) encounter fatigue which can profoundly diminish patients' quality of life, particularly during periods of disease remission when gastrointestinal symptoms have receded. Various contributing risk factors have been identified including active inflammation, anemia, psychological, lifestyle and drug-related factors. While addressing these risk factors has been suggested as the initial approach to managing fatigue, a considerable number of patients still experience persisting symptoms, the primary causes of which remain incompletely understood. Recent insights suggest that dysfunction of the gut-brain axis may play a pathogenic role. This review provides an overview of established risk factors for fatigue, alongside emerging perspectives on the role of the gut-brain axis, and potential treatment strategies.
Keywords: Crohn’s disease; fatigue; gut-brain axis; tiredness; ulcerative colitis.
Copyright © 2024 Truyens, Lernout, De Vos, Laukens and Lobaton.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
The role of virtual reality in managing inflammatory bowel disease: a novel approach to bridging mental and physical health.J Can Assoc Gastroenterol. 2025 Feb 21;8(Suppl 2):S15-S20. doi: 10.1093/jcag/gwae060. eCollection 2025 Mar. J Can Assoc Gastroenterol. 2025. PMID: 39990506 Free PMC article.
-
The potential of EGCG in modulating the oral-gut axis microbiota for treating inflammatory bowel disease.Phytomedicine. 2024 Jul 25;130:155643. doi: 10.1016/j.phymed.2024.155643. Epub 2024 Apr 14. Phytomedicine. 2024. PMID: 38820660 Review.
-
Detailed Multi-Dimensional Assessment of Fatigue in Inflammatory Bowel Disease.Inflamm Intest Dis. 2019 Apr;3(4):192-201. doi: 10.1159/000496054. Epub 2019 Mar 15. Inflamm Intest Dis. 2019. PMID: 31111036 Free PMC article.
-
Fatigue in Inflammatory Bowel Diseases: Etiologies and Management.Adv Ther. 2020 Jan;37(1):97-112. doi: 10.1007/s12325-019-01151-w. Epub 2019 Nov 23. Adv Ther. 2020. PMID: 31760611 Free PMC article. Review.
-
Health-Related Quality of Life in Patients with Inflammatory Bowel Disease in Clinical Remission: What Should We Look For?Medicina (Kaunas). 2022 Mar 27;58(4):486. doi: 10.3390/medicina58040486. Medicina (Kaunas). 2022. PMID: 35454325 Free PMC article.
Cited by
-
Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study).J Crohns Colitis. 2025 Apr 4;19(4):jjae170. doi: 10.1093/ecco-jcc/jjae170. J Crohns Colitis. 2025. PMID: 39527064 Free PMC article.
-
Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 study.J Crohns Colitis. 2025 Jul 3;19(7):jjaf100. doi: 10.1093/ecco-jcc/jjaf100. J Crohns Colitis. 2025. PMID: 40491246 Free PMC article. Clinical Trial.
-
Disease Burden and Unmet Medical Needs in Patients with Ulcerative Colitis in Greece: A Cross-Sectional Patient Survey.Med Sci (Basel). 2025 Aug 8;13(3):117. doi: 10.3390/medsci13030117. Med Sci (Basel). 2025. PMID: 40843739 Free PMC article.
-
Exploring Immune Cell Infiltration and Small Molecule Compounds for Ulcerative Colitis Treatment.Genes (Basel). 2024 Nov 29;15(12):1548. doi: 10.3390/genes15121548. Genes (Basel). 2024. PMID: 39766817 Free PMC article.
References
-
- Turner D, Ricciuto A, Lewis A, D’amico F, Dhaliwal J, Griffiths AM, et al. . STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. (2021) 160:1570–83. doi: 10.1053/j.gastro.2020.12.031, PMID: - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources